Marks, D I, Kirkwood, A A, Rowntree, C J, Aguiar, M, Bailey, K E, Beaton, B, Cahalin, P, Castleton, A Z, Clifton-Hadley, L, Copland, M, Goldstone, A H, Kelly, R, Lawrie, E, Lee, S, McMillan, A K, McMullin, M F, Menne, T F, Mitchell, R J, Moorman, A V, Patel, B, Patrick, P, Smith, P, Taussig, D, Yallop, D, Alapi, K Z & Fielding, A K 2022, ' Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial ', The Lancet Haematology, vol. 9, no. 4, pp. e262-e275 . https://doi.org/10.1016/S2352-3026(22)00038-2
Othman, J, Potter, N, Mokretar, K, Taussig, D, Khan, A, Krishnamurthy, P, Latif, A-L, Cahalin, P, Aries, J, Amer, M, Belsham, E, Conneally, E, Craddock, C, Culligan, D, Dennis, M, Duncan, C, Furness, C, Gkreka, P, Hodgson, K, Ingram, W, King, A, Kottaridis, P, McMullin, M F, Mohite, U, Ngu, L, Patrick, K, Rider, T, Roberts, W, Severinsen, M T, Storrar, N, Taylor, T, Russell, N H & Dillon, R 2022, ' High Molecular Response Rate and Overall Survival with FLT3 Inhibitors As MRD-Guided Salvage Treatment for Molecular Failure in AML ', Blood, vol. 140, no. Suppl. 1, pp. 2002-2004 . https://doi.org/10.1182/blood-2022-159503
Quek, L, Otto, G W, Garnett, C, Lhermitte, L, Karamitros, D, Stoilova, B, Lau, I J, Doondeea, J, Doondeea, B, Kennedy, A, Metzner, M, Goardon, N, Ivey, A, Allen, C, Gale, R, Davies, B, Sternberg, A, Killick, S, Hunter, H, Cahalin, P, Price, A, Carr, A, Griffiths, M, Virgo, P, Mackinnon, S, Grimwade, D, Freeman, S, Russell, N, Craddock, C, Mead, A, Peniket, A, Porcher, C & Vyas, P 2016, ' Genetically distinct leukemic stem cells in human CD34-acute myeloid leukemia are arrested at a hemopoietic precursor-like stage ', The Journal of experimental medicine, vol. 213, no. 8, pp. 1513-1535 . https://doi.org/10.1084/jem.20151775 The Journal of Experimental Medicine